- A Clinical Analysis on Liver Transplantation for Hepatocellular Carcinomas
-
Park JH, Kim DG, Choi SH, Moon IS, Lee MD, Kim IC
- KMID: 772520
- Korean J Gastroenterol.
- 2003 Jul;42(1):42-49.
BACKGROUND/AIMS: Currently, the role of liver transplantation in the treatment of hepatocellular carcinoma (HCC) with cirrhosis is controversial. What remain to be determined are the best treatment protocol and... -
- CITED
-
- Close
- SHARE
-
- Close
- Composite liver tumors: A radiologic-pathologic correlation
-
Nayyar M, Imagawa DK, Tirkes T, Demirjian , Houshyar R, Sandrasegaran K, Nangia CS, Seery T, Bhargava P, Choi JI, Lall C
- KMID: 2070261
- Clin Mol Hepatol.
- 2014 Dec;20(4):406-410.
- doi: 10.3350/cmh.2014.20.4.406
Bi-phenotypic neoplasm refers to tumors derived from a common cancer stem cell with unique capability to differentiate histologically into two distinct tumor types. Bi-phenotypic hepatocellular carcinoma-cholangiocarcinoma (HCC-CC), although a rare... -
- CITED
-
- Close
- SHARE
-
- Close
- Surgical Treatment of Sclerosing Hepatocellular Carcinoma
-
Kim BS, Lee SG, Hwang S, Lee YJ, Park KM, Kim KH, Ahn CS, Moon DB, Ha TY, Song GW, Jung DH, Moon KM
- KMID: 760673
- Korean J Hepatol.
- 2006 Sep;12(3):412-419.
BACKGROUND/AIMS: Sclerosing hepatocellular carcinoma (HCC) is an unusual subtype of HCC that is characterized by an embedded dense fibrous stroma in the tubular neoplastic structures. We aimed to assess... -
- CITED
-
- Close
- SHARE
-
- Close
- The retrospective cohort study for survival rate in patients with advanced hepatocellular carcinoma receiving radiotherapy or palliative care
-
Eun HS, Kim MJ, Kim HJ, Ko KH, Moon HS, Lee ES, Kim SH, Lee HY, Lee BS
- KMID: 1025198
- Korean J Hepatol.
- 2011 Sep;17(3):189-198.
- doi: 10.3350/kjhep.2011.17.3.189
BACKGROUND/AIMS: This study was conducted to investigate the assessment of treatment efficacy of radiotherapy (RT) and other therapeutic modalities compared with palliative care only for treatment with advanced hepatocellular carcinoma... -
- CITED
-
- Close
- SHARE
-
- Close
- Transcatheter Arterial Chemoembolization Plus ¹³¹I-Labelled Metuximab versus Transcatheter Arterial Chemoembolization Alone in Intermediate/Advanced Stage Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
-
Zhu ZX, Liao MH, Wang XX, Huang JW
- KMID: 2466285
- Korean J Radiol.
- 2016 Dec;17(6):882-892.
- doi: 10.3348/kjr.2016.17.6.882
OBJECTIVE: The aim of the study was to compare transcatheter arterial chemoembolization (TACE) plus ¹³¹I-labelled metuximab with TACE alone for hepatocellular carcinoma (HCC). MATERIALS AND METHODS: A comprehensive search was conducted... -
- CITED
-
- Close
- SHARE
-
- Close
- Transcatheter Arterial Chemoembolization for Infiltrative Hepatocellular Carcinoma: Clinical Safety and Efficacy and Factors Influencing Patient Survival
-
Han K, Kim JH, Yoon HM, Kim EJ, Gwon DI, Ko GY, Yoon HK, Ko HK
- KMID: 1731050
- Korean J Radiol.
- 2014 Aug;15(4):464-471.
- doi: 10.3348/kjr.2014.15.4.464
OBJECTIVE: To evaluate the safety and efficacy of transcatheter arterial chemoembolization (TACE) in patients with infiltrative hepatocellular carcinoma (HCC) and to identify the prognostic factors associated with patient survival. MATERIALS AND... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical significance and predictive factors of early massive recurrence after radiofrequency ablation in patients with a single small hepatocellular carcinoma
-
Cho JY, Choi MS, Lee GS, Sohn W, Ahn J, Sinn DH, Gwak GY, Paik YH, Lee JH, Koh KC, Paik SW
- KMID: 2373152
- Clin Mol Hepatol.
- 2016 Dec;22(4):477-486.
- doi: 10.3350/cmh.2016.0048
BACKGROUND/AIMS: Radiofrequency ablation (RFA) is one of the most frequently applied curative treatments in patients with a single small hepatocellular carcinoma (HCC). However, the clinical significance of and risk factors... -
- CITED
-
- Close
- SHARE
-
- Close
- Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma
-
Song MJ, Bae SH, Lee JS, Lee SW, Song DS, You CR, Choi JY, Yoon SK
- KMID: 2373799
- Korean J Intern Med.
- 2016 Mar;31(2):242-252.
- doi: 10.3904/kjim.2015.112
BACKGROUND/AIMS: We compared the recurrence of hepatocellular carcinoma (HCC) and the survival of patients who received radiofrequency ablation (RFA) after transarterial chemoembolization (TACE) with patients treated with TACE or RFA... -
- CITED
-
- Close
- SHARE
-
- Close
- Patterns of Treatment for Metastatic Pathological Fractures of the Spine: The Efficacy of Each Treatment Modality
-
Cho JH, Ha JK, Hwang CJ, Lee DH, Lee CS
- KMID: 2360262
- Clin Orthop Surg.
- 2015 Dec;7(4):476-482.
- doi: 10.4055/cios.2015.7.4.476
BACKGROUND: Metastatic pathological fractures of the spine are a major problem for cancer patients; however, there is no consensus on treatment strategy. The purpose of this study was to evaluate... -
- CITED
-
- Close
- SHARE
-
- Close
- Concurrent Chemoradiotherapy Shows Long-Term Survival after Conversion from Locally Advanced to Resectable Hepatocellular Carcinoma
-
Lee IJ, Kim JW, Han KH, Kim JK, Kim KS, Choi JS, Park YN, Seong J
- KMID: 2070195
- Yonsei Med J.
- 2014 Nov;55(6):1489-1497.
- doi: 10.3349/ymj.2014.55.6.1489
PURPOSE: For locally unresectable hepatocellular carcinoma (HCC) patients, concurrent chemoradiotherapy (CCRT) has been applied as a loco-regional treatment. After shrinkage of tumors in selected patients, surgical resection is performed. The... -
- CITED
-
- Close
- SHARE
-
- Close
- Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma
-
Kim JY, Sinn DH, Gwak GY, Choi GS, Saleh AM, Joh JW, Cho SK, Shin SW, Carriere K, Ahn JH, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW
- KMID: 2373121
- Clin Mol Hepatol.
- 2016 Jun;22(2):250-258.
- doi: 10.3350/cmh.2016.0015
BACKGROUND/AIMS: Several studies have suggested that surgical resection (SR) can provide a survival benefit over transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC) at the intermediate stage according to the Barcelona... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of immunosuppressant therapy on early recurrence of hepatocellular carcinoma after liver transplantation
-
Lee JY, Kim YH, Yi NJ, Kim HS, Lee HS, Lee BK, Kim H, Choi YR, Hong G, Lee KW, Suh KS
- KMID: 1788569
- Clin Mol Hepatol.
- 2014 Jun;20(2):192-203.
- doi: 10.3350/cmh.2014.20.2.192
BACKGROUND/AIMS: The most commonly used immunosuppressant therapy after liver transplantation (LT) is a combination of tacrolimus and steroid. Basiliximab induction has recently been introduced; however, the most appropriate immunosuppression for... -
- CITED
-
- Close
- SHARE
-
- Close
